The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members


Priorities in 2018

→ Further develop a comprehensive position for Avicenna on what is needed in EU research;
→ Launch of the new Avicenna Alliance internship scheme;
→ A core focus of the VPH membership is on the FET Flagship on ageing and on shaping this Flagship programme;
→ Contribute to the three upcoming Avicenna Alliance White Papers

Working group leader:

  • Liesbet Geris
  • Executive Director, VPH Institute
  • Professor, University of Liège & KU Leuven (Belgium)

Avicenna Alliance news

The Avicenna Alliance co-organises a public workshop at the FDA on good simulation practices in health technologies

The Avicenna Alliance, the Medical Device Innovation Consortium (MDIC) and the...

find out more ›

The Avicenna Alliance nominated as a member of the European Commission's "eHealth Stakeholder Group"

On 3 February, Thierry Marchal, Secretary-General of the Avicenna Alliance has been informed that...

find out more ›

Avicenna Alliance puts forward questions to EU Expert Panel on effective ways of investing in health

On 17 December the European Commission launched a survey inviting stakeholders to put forward...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up